Ophthalmology Times

AAO 2026: Elegrobart reduces proptosis in active thyroid eye disease

At AAO 2026, Michael T. Yen, MD, reviewed REVEAL-1 efficacy and hearing safety data for subcutaneous elegrobart in active TED ...
WebMD

Treating Thyroid Eye Disease With Lumvoa

Thyroid eye disease (TED) is an autoimmune condition that causes swelling and inflammation of the eyes. TED is often associated with hyperthyroidism (an overactive thyroid gland) and Graves’ disease ...
Healio

Management of Thyroid Eye Disease

Local ocular measures and lifestyle changes form the basis of the general management of TED, regardless of severity. Corneal exposure and dry eye symptoms can be prevented or managed with lubricant ...
UUHC Health Feed

What Is Thyroid Eye Disease, And When Does It Require Surgery?

Thyroid eye disease (TED), also known as Graves’ eye disease, usually stems from an autoimmune condition that starts when immune cells attack the thyroid gland, a tiny butterfly-shaped gland at the ...
The Pharma Letter

Innovent's Sycume meets primary endpoint in Phase III trial in inactive thyroid eye disease

Innovent Biologics, the Chinese biopharma company, said its anti-IGF-1R antibody Sycume (teprotumumab N01 injection; IBI311) met its primary endpoint in the Phase III RESTORE-3 trial in Chinese ...

Raymond Douglas, MD, PhD, Unveils Research on Six-Week Teprotumumab Dosing to Help Protect Hearing

Raymond Douglas, MD, PhD, a lead scientist behind the first FDA-approved treatment for thyroid eye disease (TED) and a 2026 ASOPRS Outstanding Contribution Award recipient, presented research at the ...
Ophthalmology Times

SYCUME meets primary end point in inactive thyroid eye disease

Teprotumumab N01 injection (SYCUME, IBI311; Innovent Biologics) met the primary end point of the phase 3 RESTORE-3 trial in inactive thyroid eye disease, according to a company announcement.¹ At week ...
Healio

Treatment for thyroid eye disease in an exciting era of growth

Please provide your email address to receive an email when new articles are posted on . Teprotumumab-trbw has changed the landscape of thyroid eye disease management. Novel thyroid eye disease drugs ...

"Will my eyes stay like this forever?" What I changed after being diagnosed with Graves' disease and struggling with thyroid eye disease

I wrote this article for those suffering from Graves' disease and thyroid eye disease.I have recorded the things I tried myself and felt were effective.I also looked into how much these things are ...
Healthline

7 Complications of Graves’ Disease

Graves’ disease is an autoimmune condition that causes hyperthyroidism, or too much thyroid hormone. Over time, high thyroid hormone levels can harm your heart, bones, skin, and eyes. Common ...
Verywell Health on MSN

Thyroid stimulating hormone supports metabolism: What if it’s too high or low?

Medically reviewed by Kelly Wood, MD Key Takeaways High TSH levels can mean you have an underactive thyroid or a pituitary gland tumor.Low TSH levels can mean you have an overactive thyroid or issues ...